Roundup Record Tribune & Winnett Times -

Mexico recently ratified the United States-Mexico-Canada Agreement, the mammoth trade deal that could replace NAFTA. U.S. lawmakers would be wise to follow suit -- the pact could save and improve millions of Americans' lives by spurring the development of cutting-edge medicines.

One of the deal's most important provisions would strengthen intellectual property protections for an innovative class of medicines called biologics. Biotech companies manufacture these large-molecule drugs from living organisms like animal or plant cells.

Doctors use biologics to treat everything from cancer and di...